齐默巴奥米特控股 ZBH 深 沪
已收盘 12-12 16:00:00 美东时间
91.59
-0.860
-0.93%
华盛通- 最 高93.16
- 今 开92.60
- 成交量 273.42万股
- 最 低 90.57
- 昨 收 92.45
- 总市值 181.35亿
- 52周最高 113.96
- 市盈率 静 20.66
- 换手率 1.38%
- 52周最低 85.33
- 委 比 15.61%
- 总股本 1.98亿
- 历史最高 172.24
- 量 比 1.11
- 振 幅 2.80%
- 历史最低 31.94
- 每 手 1
- 风险率 6.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $94
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $98 to $94.
12-12 05:07
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.
11-06 02:23
Zimmer Biomet Holdings are trading lower after the company reported mixed Q3 financial results.
Zimmer Biomet Holdings are trading lower after the company reported mixed Q3 fi...
11-05 21:29
财报速睇 | 齐默巴奥米特控股2025财年Q3营收20.01亿美元，股权持有人应占溢利2.31亿美元
华盛资讯11月5日讯，ZIMMER BIOMET HOLDINGS, INC.公司今日公布2025财年Q3业绩，公司Q3营收20.01亿美元，同比增长9.7%，股权持有人应占溢利2.31亿美元，同比下滑7.2%。
11-05 20:01
Zimmer Biomet Holdings Q3 Adj. EPS $1.90 Beats $1.87 Estimate, Sales $2.001B Miss $2.005B Estimate
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.87 by 1.71 percent. This is a 9.2 percent increase over earnings of $1.74 per share from
11-05 19:31
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
